Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 12/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.66 |
| ▸ | GLA | P06280 | 1/20 | 0.66 |
| ▸ | GAA | P10253 | 1/20 | 0.66 |
| ▸ | PKM | P14618 | 1/20 | 0.66 |
| ▸ | HPGD | P15428 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | SULT1A1 | P50225 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.62 |
| ▸ | RELA | Q04206 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | RAB9A | P51151 | 1/20 | 0.56 |
| ▸ | MAOB | P27338 | 1/20 | 0.55 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dimethylamine SCHEMBL27718704 | 0.94 | APP (0.72) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL13645837 | 0.87 | APP (0.60) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL27897630 | 0.86 | AHR (0.58) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL4804599 | 0.83 | APP (0.82) | APPSMN1; SMN2KDM4EMAPTALDH1A1 | |
| SCHEMBL15425178 | 0.83 | APP (0.82) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL1977616 | 0.83 | APP (1.00) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL12207347 | 0.83 | APP (1.00) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL2137760 | 0.83 | APP (0.67) | APPSMN1; SMN2KDM4EMAPTALDH1A1 | |
| SCHEMBL27557650 | 0.82 | APP (0.63) | APPSMN1; SMN2KDM4EMAPTMEN1 | |
| SCHEMBL12408902 | 0.82 | KDM4E (0.70) | APPSMN1; SMN2KDM4EMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119841790-A | Method for preparing 2-substituted benzothiazole derivatives by driving light | 中国科学院大连化学物理研究所 | 2025-04-18 | — | — | CN | disclosed |
| WO-2023123673-A1 | NON-AQUEOUS ELECTROLYTE AND LITHIUM-ION BATTERY COMPRISING NON-AQUEOUS ELECTROLYTE | 张家港市国泰华荣化工新材料有限公司 | 2023-07-06 | — | — | WO | disclosed |
| CN-111793040-B | Preparation method of 2-substituted benzothiazole | 太原理工大学 | 2023-01-03 | — | — | CN | disclosed |
| CN-111793040-A | Preparation method of 2-substituted benzothiazole | 太原理工大学 | 2020-10-20 | — | — | CN | disclosed |
| US-8242278-B2 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-14 | — | — | US | disclosed |
| US-20120101278-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | HAGIYA KOJI (JP) | 2012-04-26 | — | — | US | disclosed |
| EP-1473286-B1 | PROCESS FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2009-11-04 | — | — | EP | disclosed |
| US-20090216017-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | HAGIYA KOJI | 2009-08-27 | — | — | US | disclosed |
| US-7554000-B2 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-30 | — | — | US | disclosed |
| CN-1303043-C | Process for producing biaryl compound | SUMITOMO CHEMICAL CO (JP) | 2007-03-07 | — | — | CN | disclosed |
| CN-1642879-A | Process for preparing diaryl compounds | SUMITOMO CHEMICAL CO (JP) | 2005-07-20 | — | — | CN | disclosed |
| US-20050096471-A1 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-05-05 | — | — | US | disclosed |
| EP-1473286-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2004-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101278-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | PPOX, CAT, TYR | APP 1198/4885SMN1; SMN2 4152/4885KDM4E 3428/4885 |
| US-20090216017-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | PPOX, CAT, TYR | APP 1198/4885SMN1; SMN2 4152/4885KDM4E 3428/4885 |
| US-20050096471-A1 | Process for producing biaryl compound | PPOX, CAT, TYR | APP 1198/4885SMN1; SMN2 4152/4885KDM4E 3428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.